254 related articles for article (PubMed ID: 22198767)
21. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
[TBL] [Abstract][Full Text] [Related]
22. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments.
Sblattero D; Florian F; Azzoni E; Zyla T; Park M; Baldas V; Not T; Ventura A; Bradbury A; Marzari R
Eur J Biochem; 2002 Nov; 269(21):5175-81. PubMed ID: 12392549
[TBL] [Abstract][Full Text] [Related]
23. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
Paolella G; Nanayakkara M; Sposito S; Lepretti M; Auricchio S; Esposito C; Barone MV; Martucciello S; Caputo I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059410
[TBL] [Abstract][Full Text] [Related]
24. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
25. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
Qiao SW; Piper J; Haraldsen G; Oynebråten I; Fleckenstein B; Molberg O; Khosla C; Sollid LM
J Immunol; 2005 Feb; 174(3):1657-63. PubMed ID: 15661929
[TBL] [Abstract][Full Text] [Related]
26. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
27. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
[TBL] [Abstract][Full Text] [Related]
28. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
[TBL] [Abstract][Full Text] [Related]
29. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
[TBL] [Abstract][Full Text] [Related]
30. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.
Marzari R; Sblattero D; Florian F; Tongiorgi E; Not T; Tommasini A; Ventura A; Bradbury A
J Immunol; 2001 Mar; 166(6):4170-6. PubMed ID: 11238668
[TBL] [Abstract][Full Text] [Related]
31. Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2.
Lindfors K; Koskinen O; Kurppa K; Laurila K; Collin P; Haimila K; Partanen J; Saavalainen P; Mäki M; Kaukinen K
J Clin Immunol; 2011 Jun; 31(3):436-42. PubMed ID: 21384250
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
[TBL] [Abstract][Full Text] [Related]
33. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
[TBL] [Abstract][Full Text] [Related]
34. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
[TBL] [Abstract][Full Text] [Related]
35. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
36. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
37. Epitope mapping of the N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease.
Di Pisa M; Buccato P; Sabatino G; Real Fernández F; Berti B; Cocola F; Papini AM; Rovero P
J Pept Sci; 2014 Sep; 20(9):689-95. PubMed ID: 24831711
[TBL] [Abstract][Full Text] [Related]
38. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
39. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
40. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
